21 January 2014 07:14 [Source: ICIS news]
SINGAPORE (ICIS)--DSM’s net sales increased by 4.76% year on year at €2.38bn in the fourth quarter, the Netherlands-based firm said on Tuesday.
The company's earnings before interest, tax, depreciation and amortisation (EBITDA) in the fourth quater rose by 30% year on year to €316m, the company said in a statement.
For the full year of 2013, the company’s EBITDA rose by 18.5% to €1.31bn compared with the previous year, while its net sales rose 5.3% to €9.62bn, it added.
“Despite the moderate Q4 results in [the] nutrition [business], due to currencies and market weakness, DSM’s market positions remained strong,” the company said.
“In the short term our focus will continue on the operational performance of our businesses, supported by our Profit Improvement Program and intensified R&D and innovation programs,” it added.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections